SARS-CoV-2 reinfection and implications for vaccine development
Publication Name : Human Vaccines and Immunotherapeutics
DOI : 10.1080/21645515.2020.1830683
Date : 2020
Type
Journal
ISSN
21645515
Volume
16
Page
3061-3073